0001117768-15-000830.txt : 20151117 0001117768-15-000830.hdr.sgml : 20151117 20151117150342 ACCESSION NUMBER: 0001117768-15-000830 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20151117 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151117 DATE AS OF CHANGE: 20151117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HealthWarehouse.com, Inc. CENTRAL INDEX KEY: 0000754813 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 222413505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13117 FILM NUMBER: 151238013 BUSINESS ADDRESS: STREET 1: 7107 INDUSTRIAL ROAD CITY: FLORENCE STATE: KY ZIP: 41042 BUSINESS PHONE: (513) 618-0911 MAIL ADDRESS: STREET 1: 7107 INDUSTRIAL ROAD CITY: FLORENCE STATE: KY ZIP: 41042 FORMER COMPANY: FORMER CONFORMED NAME: HealthWarehouse, Inc. DATE OF NAME CHANGE: 20090818 FORMER COMPANY: FORMER CONFORMED NAME: CLACENDIX, INC. DATE OF NAME CHANGE: 20080107 FORMER COMPANY: FORMER CONFORMED NAME: ION NETWORKS INC DATE OF NAME CHANGE: 19990413 8-K 1 mainbody.htm MAINBODY mainbody.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported):  November 17, 2015
logo
HealthWarehouse.com, Inc.
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware
 
0-13117
 
22-2413505
(State or other jurisdiction
 
(Commission File Number)
 
(IRS Employer
of incorporation)
     
Identification No.)

7107 Industrial Road
   
 Florence, Kentucky
 
41042
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code:  (800) 748-7001

Not Applicable
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
  o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
  o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)
   
  o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
  o
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 

 
 

 

 
 
 
 

Item 2.02    Results of Operations and Financial Condition

On November 17, 2015, HealthWarehouse.com, Inc. (the “Company”) issued a press release announcing its results of operations for the quarter and nine months ended September 30, 2015.  A copy of the press release is included as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01     Financial Statements and Exhibits

(a)           Not applicable.

(b)           Not applicable.

(c)           Not applicable.

(d)           Exhibits

The following exhibits are included herewith.


*     The press release furnished as Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

 
 
 
 
 
 
 
 
- 2 -

 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
HEALTHWAREHOUSE.COM, INC.
   
   
   
Date:  November 17, 2015
By: /s/  Lalit Dhadphale                                                                         
 
 Lalit Dhadphale
 
 President and Chief Executive Officer


 
 
 
 
 
 
 
 
 
 
 

 

 
- 3 -

 

EX-99.1 2 exhibit991.htm EXHIBIT991 exhibit991.htm
Exhibit 99.1
 
 

 
HealthWarehouse.com Reports 14.5% Quarterly Sales Growth Year over Year
New Customers Grow 70.3% as Prescription Drug Orders Grow 17.3%
 
 
(CINCINNATI, OH, November 17, 2015) -– HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced financial results for the quarter ended September 30, 2015.
 
Net sales for the three months ended September 30, 2015 increased to $1,689,457 from $1,474,986, an increase of $214,471, or 14.5%, resulting from growth in core prescription and over-the-counter sales offset by a reduction in business-to-business sales.  Core over-the-counter revenue grew 40.3% and orders grew by 44.3% due to advertising efforts and improved order fulfillment rates and customer satisfaction.  Core prescription orders grew 17.3% as new customers grew 70.3% and repeat customers grew 22.1%, continuing the reversal of the downward trend experienced during 2014 due to lack of advertising efforts in the first three quarters of 2014.
 
Net sales for the nine months ended September 30, 2015 increased to $5,172,974 from $4,654,404, an increase of $518,570, or 11.1%, resulting from growth in core prescription, over-the-counter and business-to-business sales.  
 
The Company plans to continue to focus on customer acquisition, conversion and retention.  The Company believes this strategy has helped to increase new customers by 70.3% and overall orders by 25.9% during the third quarter of 2015 compared to levels experienced prior to the completion of the equity raise in October 2014.  The Company believes repeat customers will also continue to grow through the retention of the new customers acquired over the past twelve months.
 
Lalit Dhadphale, President & CEO of HealthWarehouse.com stated, “New customers continue to find HealthWarehouse.com as a cost-saving solution for their prescription drugs and over-the-counter products.  With Affordable Care Act and changes to Medicare Part D, Americans are finding affordability for prescription drugs increasingly challenging, as out of pocket costs continue rise.  HealthWarehouse.com continues to be the leader in providing transparent, affordable drug prices.”
 
In October 2015 a customer shared this review with HealthWarehouse.com, The cost of prescription medicines is overwhelming; my heart breaks for people both young and old, who do not know to price their medications through HealthWarehouse.com. Thank you for all you do to help make a chronic situation a bit more manageable.”
 
3rd Quarter 2015 Highlights:
 
  
Net Sales:  Increased by $214,471 or 14.5% compared to the 3rd Quarter of 2014 due to growth in core prescription and over-the-counter sales.
 
  
Gross Margin:  Increased to 64.2% from 59.3% compared to the 3rd Quarter of 2014.
 
  
Net Loss:  Improved by $367,653 or 69%  compared to the 3rd Quarter of 2014 as a result of the increased net sales, improved gross margins and reduced operating expenses.
 
  
EBITDAS:  Improved by $128,000 to $(38,161) compared to the 3rd Quarter of 2014.
 
Year to Date 2015 Highlights:
 
  
Net Sales:  Increased by $518,570 or 11.1% compared to the first nine months of 2014 due to growth in core prescription, over-the-counter and business-to-business sales. 
 
  
Gross Margin:  Increased to 64.2% from 58.7% compared to the first nine months of 2014.
 
  
Net Loss:  Improved by $757,867 or 63% compared to the first nine months of 2014 as a result of the increased net sales, improved gross margins and reduced operating expenses.
 
  
EBITDAS:  Improved by $210,199 to $6,041 compared to the first nine months of 2014.
 
 
 
 
 

 
Page 1 of 2

 
 
 
 
 
 
About HealthWarehouse.com
 
HealthWarehouse.com, Inc. (OTCQB:HEWA) is a trusted VIPPS accredited online pharmacy based in Florence, Kentucky.  The Company is focused on the growing out of pocket prescription market, which is expected to grow to $80 billion in 2015.  With a mission to provide affordable healthcare to every American by focusing on technology that is revolutionizing prescription delivery, HealthWarehouse.com has become the largest VIPPS accredited online pharmacy in the United States.
 
HealthWarehouse.com is licensed in all 50 states and only sells drugs that are FDA-approved and legal for sale in the United States. Visit HealthWarehouse.com online at http://www.HealthWarehouse.com.
 
Forward-Looking Statements
 
This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ significantly from management's expectations. These forward-looking statements involve risks and uncertainties that include, among others, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, inventory, government regulation and taxation, payments and fraud. More information about factors that potentially could affect HealthWarehouse.com's financial results is included in HealthWarehouse.com's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings.
 
Use of Non-GAAP Measures
 
HealthWarehouse.com, Inc. (the "Company") prepares its condensed consolidated financial statements in accordance with the United States generally accepted accounting principles ("U.S. GAAP"). In addition to disclosing financial results prepared in accordance with U.S. GAAP, the Company discloses information regarding adjusted EBITDAS, which differs from the term EBITDA as it is commonly used. In addition to adjusting operating loss to exclude interest, depreciation and amortization, adjusted EBITDAS also excludes stock issued for services, and certain other non-cash charges. Adjusted EBITDAS is not a measure of performance defined in accordance with U.S. GAAP. However, adjusted EBITDAS is used internally in planning and evaluating the Company`s performance. Accordingly, management believes that disclosure of this metric offers investors, bankers and other shareholders an additional view of the Company`s operations that, when coupled with the GAAP results, provides a more complete understanding of the Company’s financial results.
 
Adjusted EBITDAS should not be considered as an alternative to net loss or to net cash used in operating activities as a measure of operating results or of liquidity. It may not be comparable to similarly titled measures used by other companies, and it excludes financial information that some may consider important in evaluating the Company`s performance. A reconciliation of U.S. GAAP net loss to adjusted EBITDAS is included in the accompanying financial schedules.
 
Contact:
 
Mr. Lalit Dhadphale, CEO
lalit@healthwarehouse.com, (859) 444-7341

 
 
 
 
 
 

 
 
Page 1 of 2

 
GRAPHIC 3 logo.jpg LOGO begin 644 logo.jpg M_]C_X 02D9)1@ ! @$ ;@!N #_X@Q824-#7U!23T9)3$4 0$ Q(3&EN M;P(0 !M;G1R4D="(%A96B 'S@ " D !@ Q !A8W-P35-&5 !)14,@ M0 9&5S8P 2D! M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+! M LL"U0+@ NL"]0, PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H# MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P M!/X%#044%]@8&!A8&)P8W!D@& M609J!GL&C :=!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0) MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X- M^ X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3 M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8# M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 9 M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC M',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@ M;""8(,0@\"$<(4@A=2&A(B>K)]PH#2@_*'$H MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT, M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<-]1B)&9T:K1O!'-4=[1\!( M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE M3FY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4 MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5 M6^5<-5R&7-9=)UUX7&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB M\&-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I( M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5&YXS'DJ>8EYYWI& M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*" M](-7@[J$'82 A..%1X6KA@Z&I+CDTV3MI0@E(J4 M])5?EAMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H M4JC$J3>IJ:H_ MR#W(O,DZR;G*.,JWRS;+MLPUS+7--:6YQ_GJ>@RZ+SI1NG0ZEOJ MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q)QL4)"'AXC(R,C M)R'AXC(R,C)R'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! M ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ M $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A M)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# !$0(1 #\ M]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "O/?A[JFI7NM317EW/<(+)V"2R/(H821#.&8 MC.":N:WHOB^TOY[G0;F1K2X=Y?)23'EECO?"N<G?;;N=5XPU+4;7Q+:P M6UU/#$QBW1QR.B')7.0"!7;W-Y:6:>9>3QVZ'@-*ZQK^;$>M>2:GJ&JW.HV\ MVJQNU[!( RE!$S;6!5< 8SQC@5;O]1T_6O%CS:W,RZ4U92=DKWW[6/4+:]L[U2]G/%<*."T3K(!^*DU M%/J^E6K^5QEE6[NY]5N9-W_'H%V+N'!7;M0D9X&X@8QCM3Y_3[ MS18AM:**:DTVY::=NKN=QJE[%+H-_=V$ZN$L[DI- X;#+&Q!#*>"#7)>#/$% MQ#I^K7NIW3W'V=(FA2XF8[GVSMY:ERV"VSL*Q/#4[0MK%M$SF*72KT;6RH.Q M&*L5R1N_EDU)X>TR#4_#^M^>SK]D2*[CV$#+Q17.T'(/R\\XQ]:7,VT_)F?M MI3E"459\L]+Z729U'A/Q>^K27KZO/;VRJ8?L\9*Q#!#[\;FRW09YK'\":Y=/ MJTYU;4)&@6R=O]*F8QAO,B /SM@'!-5? _AVRUQ[J6[>5&M3%L\HJH/F"0'. MY&_N\51\):'!X@U-[*YD>.%(&F;R\;VVE4 !(('+YS@^G?-%W[OS)4ZK]B]V MW*VN^O7T/3;N]M[S3;B33;I)2@'[R"17VD$-C*MQQ5;1+V8V%S-.S2F$LXW, M2V N<9.>.*X3PA%L\5_8%=A%(+N!\$ L@1\ \>P/U KJK25[2WU&V888)@C@ MX(81D9_X'^-HX5H5+M+VN;G[5;V=J[QNXS\K%-Q<[5'!'I6--;-#9VUP<$3 M-(1W.%*CG\:O1W$=YKR3GA"5;!.0"J#^HKEIU)JFZ,I-.I4I:WUY9J[U^2^\ M:;MROJU]S-[[7:0@12W$8=0 0S@'(_WF)_,U)Y\/E^=YB^6,?/N&WGISG'>N M97.T'*_WCBJVER+:ZJB02[XY"(RX4@,&P<889'(IFD6":A<-%*Q M5%0N=N,G! QSGU]*SEBIUIT7"/OJE].AU<4T,PW M0NL@!P2A##],TV2ZM83MEFCC/HS*I_4US%J\VGW5U'%(<1K*AQP&*A]K=\$$ M9J71]-CU-II[IV(!QP?F+-SN).:UCC9U.6$*:]I)R33E[JY?,I5&[)+5W]-# MI/-B\OS=Z^7C._(VX^O2DBG@FSY,BR;<9V,&QGIT)]*Y(226,EW9AMT;;XVX MZ[20K=>#FM+PM_R]?]LO_9Z=+&NK5A3Y+.7,I:WLXIO3RT"-3FDE;O?Y&W'< M6\Q*PRI(0,D*P8X_ TS[;9[MGGQ;LXV[USGTQFN4L?/\NZ^SYW?9\,!G=M+* M#C^OM4VF6VFW+>3=.\4V[Y<$*I]N5/-1''SGR)0BG._Q2LM':R?<2JMVT6O= MG4O+%&GF2.J)Q\S$!>>G)IL5S;S'$,J2$==C*W\B:YS6'1M22SD;9;6XC0#D M[00I)Z$]#44\UK:ZC'-I3$QC82!O'.>5^;!(./UJIX[EG)6$U%^][U^K2 MMJDQNK9O:R=M]3K:A>\M(VV23QHPZAG4']35;6KJ2TL6>)MKLP0$=1G.0C[AMY]\XI(KFVG)$,J2$=0C*Q_0FN8EM_M.HKIENS>5$[1KO.2,?Z MQNH'8_@!4FLZ=%ICP26K,-VX\GD%-N"",>M9/&U.66C/Y:SQE\XVAU+9],9S6+=^-M(LKJ>TF2?=;LR,P6/867/ S M(#U&!D#\JJZOI<>FK"T3LY<'=NQC*[>1P..>E7[/0='O;1;FZM(Y9;A=\KL. M7;)Y.,<^]:T<14J5)TIP4)02>CNK.W^8.523Y8V37?70U+&\BU"SAOH PCN( MUD4.-K ,,X(YYHJ2&&.WA2"%0D<2*B*.@51@ ?@**Z317TOVU]1]>9_#/_D/ M3_\ 7A)_Z,AKTRL4>,?#AVXN\[NG[J;'?_IG[4E MM[V.3\;_ /(U6?\ O0_^A)534]-'AGQ+]KN;,7M@9)'2$@M&4D5PBG>K@E?Q MZ5WT6>,Q3+-(C?>1[2Z93WY!@(J'%7=W M9WZ@\#4G>:C)\TE)/D;7_!3.5BUS0M7'G>,G)*46_LJWW=T>5Z)+))>ZJ\R['ETW479<$8)C=B.?K6MX$MY+O2- M?M81F2>U2-!P,LZ3J!S@=37HU%"A;KW_ !%##0W31!G_Z\)/\ T9#7HWV*S-R+PP1?: ," M;8OFXQC&[&>G'6GM-"DBQ.ZK(_W4) 8_0=30H6MKL$,/*+A>=U3;LK=_.YYC MX3_Y'A?^NMY_Z!)71:PGEZE.@YW.&_[Z ;^M=?39)(XD,DK!$'5F(51GCJ:Q MQ&%]O!0YN6TKWM?I:VZ*A0Y8N/->\F[V[K;M5O#/_'W)_UQ/_H2UT,<440VQ(J#T4!1^E*\D<>WS'5-[!%W M$#+'HHSU/M3CA90#:1P05W <$>IKJP H"J, # X JNSZ=YGFLT M'F!_+WDIOWC'R9ZYZ<4E@7!PG3J6G%N\FKWYM] ]E:S3U[^IS>D7?V%I[G9O M C"XSMZL.^#Z4R^GM;QD:TMVAD)PX!RI)Z #UKL*CCM[>%BT,21LW4JH4G\ MA2> GR*E[5."O>\%>][W3NW^(>R=K7T]#F+R"\M)8+VY7S?-2,OO& M-!^\95!X^8@ _G4,8L8%,D7E1*3@L MNQ1DXXR,52P MP.3ZXIVGZU)I\'V62 OY;,<[B,9[8P>^:Z4*H8L S8W$#DXZ9I&1&(+*&*G M() ./I36$J1DIJL_:6:UFP]FT[\VO>QRC3S17RZK%"R([F3;U')*NN M[;CGGMQFI=0NY=:FAAMX65D#<'DY8C/IQP.:ZBFHB1C$:A03DA0 ,^O%+ZC* MTH>U?).2?+^S(6 X^4(*E\3*S3P[0 M3^[;ISWKH:*IX).%2"G95)J6VUGMOJ/V>C5]WN^ES2E['7VM^EK.W> M_1G':>NCVMOY5Y9F\E+%C,\$RL,;OEQU&3@"C4-/AU* 6\Y95# MAP4(#9 ([@^M6<,G=M]VS'.JZQY?GQF(J]ZUI&K#G<254]N,^]+<:QJ=H+FW ME,;3Q36\:/@A?WH=LX&<\)T]ZTET>V6)(0TFV.[%V#E<[P2V#\O3)_\ KT3Z M/:W$LT[O(KS/"Y*L%*M""JE>./O=\T",P:QJGDL5"N_VFWBB+(8PWF%@1R1W M ^E+?2WEG<6=Q?K'-,K7#+LW !512!V&>3S@UI_V5&P42SSR[9XIQYCAL-&2 MP ^7 '/.*DO-.M[Z2*2?=^YW@*" I#@ @\9Z#L10!1M;G69;5;YY+9(WC+[9 M<@*"/E)*]/?G]:K6]W^>#>&@VXA M-OY]P82"/*\S"#/7@*/R/%/MM&@M;F.Y2:9FBC,2JS+LV8P$P%' Z@>M %9= M1O?[6:VF>."+SMD:.K;G7U#;=N3]:EUZVM_[/GN/*3SOD_>;5W_>5>N,].*G M?2HI9UGEFF<)-YRQL^8PV:? M.W&>>N?:KYT*W;RE>>X9(=FR-G!C^0!1QMXZ=JDFTBWGGFF=Y<7*JLL88",[ M0 IQMSD8SU_3(H RK?7-1CD5KI1+'\YD$<;+A5&<@MMYI99-4GCT^YO&C\F: M]MG1$!WC<@Q]WWJH^TR^6Z MAE?7G4YR,9,8XP16VNE6ZP06X9]MM<>>AR,EMS-@_+TRQIIT:U+A]TF1>&[Z MKC>2IQ]W[OR__7H SFU/6%T\ZF3$84;&W'S,-Q0GVYXIESKFI+=7*0!2L$Q1 M(]C.2%."20!CIZUK-I5NVG'3"S^4<_-E=_+^9UVXZ^U,;1H?.EGBGGA,S[Y! M$X0$\_[.>Y[T 4]>DCE73I64O&]S&Q0J68J2IV[>G7'UKH+NQAO'@>4L#;RK*FT@ E2" <@\<4^ZM8[N+RI"0 MNX-\N M7;&59%1U (=%X#!6^%Y)W;>/;CVZUMSV$,\=O$Y8"UEBE3!&28ON@\'CUJ!] M%M9(;J M)MO9/,D(*Y!W;OE^7IGUS0!FW>NW=MNN!+;RH&1A;Q[F.QB1AGQM M5L?K^1M6UWJVH-<2VC11QPSF)$D!^; !))&2."*.%R!SZ_TH H)K.H&,V)V'46N?*3@ MJ@3AMY!'U%;]8\5LTGB2:XDB=%CA'EOM/ENQ 4G<21G!P /QY'.Q0 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end